Effectiveness of Cabergoline Treatment in Patients with Acromegaly Uncontrolled with SSAs: Experience of a Single Tertiary Center

---

Sahin S., Fidan M. C., Korkmaz O. P., DURCAN E., ÖZKAYA H. M., KADIOĞLU P.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.129, no.9, pp.644-650, 2021 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 129 Issue: 9
• Publication Date: 2021
• Doi Number: 10.1055/a-1274-1276
• Journal Name: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
• Page Numbers: pp.644-650
• Keywords: Acromegaly, cabergoline, combined therapy, somatostatin analogue
• Istanbul University Affiliated: Yes

Abstract

Purpose To evaluate the effectiveness of cabergoline and the parameters affecting cabergoline response as add-on treatment to somatostatin analaogues (SSA) in patients with acromegaly uncontrolled with SSAs.